ABOUT GLEDEPA MET XR 500

Gledepa Met XR 10/500 Tablet is used to treat Type 2 diabetes. Type 2 diabetes is a common condition that causes the level of glucose (sugar) in the blood to become too high. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups to lead a normal life.

Gledepa Met XR 10/500 Tablet is composed of dapagliflozin and metformin. This medicine works by blocking the sodium-glucose co-transporter-2 (SGLT-2) enzyme. This lowers renal reabsorption of glucose and increases urine excretion of glucose via inhibiting SGLT2.

In some cases, you may experience specific common side effects, such as frequent urination, mild skin rash or itchy skin, or diarrhoea, stomach ache, and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. The dosage is based on your medical condition and response to treatment. To help you remember, take it at the same time each day. Tell your doctor if your condition does not improve or worsens (if your blood sugar is too high or too low).

Do not take Gledepa Met XR 10/500 Tablet if you are allergic to any component present in Gledepa Met XR 10/500 Tablet. If you are pregnant or breastfeeding, consult your doctor before taking Gledepa Met XR 10/500 Tablet. Avoid drinking alcohol while taking Gledepa Met XR 10/500 Tablet since it may produce unpleasant side effects. Before starting Gledepa Met XR 10/500 Tablet, let your doctor know if you have any history of heart, kidney or liver disease; breathing problems; blood disorders; dehydration; alcohol use, low blood pressure; and yeast infection of the genitals. Gledepa Met XR 10/500 Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease.